STOCK TITAN

Campbell's shareholders approve 9M more incentive shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

The Campbell's Company (CPB) shareholders approved an amended and restated 2022 Long-Term Incentive Plan at the November 17, 2026 annual meeting. The plan increases shares authorized for issuance by 9,000,000, from 12,000,000 to 21,000,000 shares. The board had approved the plan subject to shareholder approval.

Shareholders also elected the director nominees, ratified PricewaterhouseCoopers LLP as the independent registered public accounting firm for fiscal 2027, and approved fiscal 2026 executive compensation on an advisory basis. A non-binding proposal for a report on the regenerative agriculture program, including pesticide reduction outcomes, was not approved.

Filing Explained

The amended plan adds a minimum one-year vesting period for awards, subject to customary exceptions, setting a floor on how quickly plan awards may vest.

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 5.07 Submission of Matters to a Vote of Security Holders Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Shares added to plan authorization 9,000,000 shares Increase under the amended and restated 2022 Long-Term Incentive Plan
Prior plan authorization 12,000,000 shares Shares authorized for issuance before amendment
New plan authorization 21,000,000 shares Total shares authorized for issuance under the amended and restated plan
Votes for plan amendment 190,336,119 votes Shareholder vote on amendment and restatement of the 2022 Long-Term Incentive Plan
Votes against plan amendment 3,578,364 votes Shareholder vote on amendment and restatement of the 2022 Long-Term Incentive Plan
Votes for shareholder proposal 8,557,797 votes Non-binding proposal for a regenerative agriculture program report
Votes against shareholder proposal 183,754,619 votes Non-binding proposal for a regenerative agriculture program report
Votes for executive compensation 189,900,688 votes Advisory vote on fiscal 2026 executive compensation
Long-Term Incentive Plan financial
"Amended and Restated 2022 Long-Term Incentive Plan"
A long-term incentive plan is a company program that pays executives or employees with stock, options, or cash tied to multi-year performance goals, where the rewards become theirs only after meeting conditions over time. Think of it as a delayed bonus or retirement-style reward that aligns employees’ interests with shareholders by encouraging them to boost long-term value; investors watch these plans because they affect pay costs, share dilution and management incentives.
minimum one-year vesting period financial
"adding a minimum one-year vesting period term for awards"
broker non-votes technical
"Broker Non-Votes"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
non-binding shareholder proposal regulatory
"A non-binding shareholder proposal regarding a report"
A non-binding shareholder proposal is a suggestion submitted by one or more shareholders for a vote at a company meeting that, even if approved by shareholders, does not legally force the company or its board to act. It matters to investors because the vote serves as a public measure of shareholder sentiment—like a customer feedback poll—and can pressure management, influence reputations, guide future policies, and signal risks or priorities that may affect the company’s long-term value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares does CPB's amended incentive plan authorize?

The amended plan authorizes 21,000,000 shares in total, an increase of 9,000,000 shares from the 12,000,000 previously authorized.

How did shareholders vote on CPB's incentive plan amendment?

The amendment received 190,336,119 votes for and 3,578,364 against. There were 504,073 abstentions and 63,887,053 broker non-votes.

Did CPB shareholders approve executive compensation?

Shareholders approved fiscal 2026 executive compensation on an advisory basis, with 189,900,688 votes for, 4,011,411 against and 506,457 abstentions; there were 63,887,053 broker non-votes.

How did shareholders vote on CPB's regenerative agriculture proposal?

The non-binding proposal was not approved; shareholders cast 8,557,797 votes for and 183,754,619 against. There were 2,106,140 abstentions and 63,887,053 broker non-votes.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
0000016732false00000167322026-11-172026-11-17

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report
(Date of Earliest Event Reported):
November 17, 2026
TCC-logo_V_red (002).jpg
THE CAMPBELL'S COMPANY
New Jersey1-382221-0419870
(State or other jurisdiction of incorporation)(Commission File Number)(IRS Employer
Identification No.)
One Campbell Place
Camden, New Jersey 08103-1799
Principal Executive Offices
Telephone Number: (856) 342-4800

Not Applicable
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Capital Stock, par value $.0375CPBThe Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐




Item 5.02 - Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
At the Annual Meeting of Shareholders of The Campbell's Company (the "Company"), which was held on November 17, 2026 (the “2026 Annual Meeting”), the Company's shareholders approved the Amended and Restated 2022 Long-Term Incentive Plan (the “Amended and Restated Plan”). The Amended and Restated Plan was previously approved, subject to shareholder approval, by the Board of Directors (the “Board”) of the Company.
The Amended and Restated Plan amends and restates in its entirety the Company's 2022 Long-Term Incentive Plan (the "2022 Plan") by (i) increasing the number of shares available for issuance by 9,000,000 shares, which increases the total number of shares authorized for issuance from 12,000,000 shares to 21,000,000 shares; (ii) adding a minimum one-year vesting period term for awards, subject to customary exceptions; and (iii) making various administrative amendments approved by the Board that do not require shareholder approval according to the 2022 Plan and the rules of The Nasdaq Stock Market. A summary of the material terms and conditions of the Amended and Restated Plan and awards thereunder is included in the Company's definitive proxy statement filed with the Securities and Exchange Commission on October 7, 2026 (the “Proxy Statement”) under “Item 4: Amendment and Restatement of the Company's 2022 Long-Term Incentive Plan,” which section is incorporated herein by reference. The foregoing descriptions are qualified in their entirety by reference to the Amended and Restated Plan, a copy of which is filed as Exhibit 10.1 hereto and incorporated herein by reference.
Item 5.07 – Submission of Matters to a Vote of Security Holders
The final results of voting with respect to each item voted on at the 2026 Annual Meeting are set forth below.
Management Proposals:
1. Election of Directors
The nominees for election to the Board were elected, each until the next Annual Meeting of Shareholders or their earlier resignation or retirement. For each nominee, the votes cast for, against, abstentions, and broker non-votes were as follows:
Director
For
Against
Abstain
Broker Non-Votes
Fabiola R. Arredondo
192,056,8801,977,415384,26163,887,053
Howard M. Averill
192,013,6362,023,713381,20763,887,053
Mick J. Beekhuizen
192,395,1061,642,094381,35663,887,053
Bennett Dorrance, Jr.
191,924,1362,124,609369,81163,887,053
Maria Teresa (Tessa) Hilado
192,070,1921,994,333354,02063,887,053
Grant H. Hill
191,753,3962,280,759384,40163,887,053
Sarah Hofstetter
191,899,3512,172,062347,14363,887,053
Marc B. Lautenbach
191,182,5792,850,787385,19063,887,053
Mary Alice D. Malone, Jr.
192,001,4672,064,189352,90063,887,053
Keith R. McLoughlin
192,019,5342,028,609370,41363,887,053
Kurt T. Schmidt
191,918,6082,123,958375,99063,887,053
Archbold D. van Beuren
190,185,1293,867,931365,49663,887,053
2. Ratification of Appointment of Independent Registered Public Accounting Firm for Fiscal 2027
The proposal to ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for fiscal 2027 was approved. The votes cast for and against this proposal as well as the abstentions were as follows:
For
Against
Abstain
254,644,8383,309,860350,248
3. Advisory Vote on Fiscal 2026 Executive Compensation
The resolution to approve, on an advisory basis, the compensation of the Company's executive officers named in the Proxy Statement for the 2026 Annual Meeting was approved. The votes cast for and against this proposal as well as the abstentions and broker non-votes were as follows:



For
Against
Abstain
Broker Non-Votes
189,900,6884,011,411506,45763,887,053
4. Amendment and Restatement of the Company's 2022 Long-Term Incentive Plan
The proposal to approve an amendment and restatement of the Company's 2022 Long-Term Incentive Plan was approved. The votes cast for and against this proposal as well as the abstentions and broker non-votes were as follows:
For
Against
Abstain
Broker Non-Votes
190,336,1193,578,364504,07363,887,053
Shareholder Proposal:
5. Regenerative Agriculture Program Report
A non-binding shareholder proposal regarding a report on the effectiveness of the Company’s regenerative agriculture program including pesticide reduction outcomes was not approved. The votes cast for and against this proposal as well as the abstentions and broker non-votes were as follows:
For
Against
Abstain
Broker Non-Votes
8,557,797183,754,6192,106,14063,887,053

Item 9.01 – Financial Statements and Exhibits
(d) Exhibits
10.1*
Amended and Restated 2022 Long-Term Incentive Plan, incorporated by reference to Appendix B to the Proxy Statement filed October 7, 2026 (Commission File No. 001-03822).
10.2*
Form of Amended and Restated 2022 Long-Term Incentive Plan Time-Lapse Restricted Stock Unit Agreement.
10.3*
Form of Amended and Restated 2022 Long-Term Incentive Plan Performance Restricted Stock Unit Agreement (Organic Net Sales Growth).
10.4*
Form of Amended and Restated 2022 Long-Term Incentive Plan Performance Restricted Stock Unit Agreement (Earnings Per Share Growth).
10.5*
Form of Amended and Restated 2022 Long-Term Incentive Plan Nonqualified Stock Option Agreement.
104The cover page from this Current Report on Form 8-K formatted in Inline XBRL.
*This exhibit is a management contract or compensatory plan or arrangement.



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

THE CAMPBELL'S COMPANY
       Date: November 18, 2026By:/s/ Charles A. Brawley, III
Charles A. Brawley, III
Executive Vice President, General Counsel and Corporate Secretary


Filing Exhibits & Attachments

7 documents

Keep reading